The np 3243 MELAS mutation: damned if you aminoacylate, damned if you don’t

Authors: Jacobs, Howard T.1; Holt, Ian J.2

Source: Human Molecular Genetics, Volume 9, Number 4, 1 March 2000 , pp. 463-465(3)

Publisher: Oxford University Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

The np 3243 MELAS mtDNA mutation in tRNAleu(UUR) has been variously proposed as a loss-of-function or as a gain-of-function mutation, based on apparently contradictory studies in cultured cell lines. A new report describing the molecular effects of the mutation in vivonow mirrors this variability. This should prompt a more systematic re-investigation of cells carrying the mutation, in order to separate primary from secondary and pathogenic from compensatory effects, all of which may contribute to disease phenotype. Nuclear genetic and developmental background, mitochondrial haplotype, and epigenetic effects may all influence the pathological outcome. Defects in both base-modification and aminoacylation of the mutant tRNA could play critical roles.

Document Type: Research article

Affiliations: 1: Institute of Medical Technology and Tampere University Hospital, University of Tampere, 33101 Tampere, Finland, 2: MRC Dunn Human Nutrition Unit, Hills Road, Cambridge CB2 2XY, UK

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$48.69 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A